Cardiology (all articles)

Research: Effect of β‐Blockers Beyond 3 Years After Acute Myocardial Infarction

8 Mar, 2018 | 22:03h | UTC

Effect of β‐Blockers Beyond 3 Years After Acute Myocardial Infarction – Journal of the American Heart Association (free for a limited period)

Systematic Review: Factor Xa inhibitors vs vitamin K antagonists in patients with atrial fibrillation

8 Mar, 2018 | 22:04h | UTC

Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation – Cochrane Library (free)

Summary: Comparing two types of blood-thinning drugs, factor Xa inhibitors and vitamin K antagonists, to prevent blood clots in people with atrial fibrillation – Cochrane Library (free)

When available, Factor Xa inhibitors seems to be a better choice for treating these patients.

Digoxin and Mortality in Patients With Atrial Fibrillation

8 Mar, 2018 | 21:42h | UTC

Digoxin and Mortality in Patients With Atrial Fibrillation – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries: Digoxin and Mortality in Patients With Atrial Fibrillation – American College of Cardiology, Latest in Cardiology (free) AND Digoxin Associated with Higher Mortality in Patients with Atrial Fibrillation – NEJM Physician’s First Watch (free)

Big Swings in Daily Temperatures Linked to Spikes in MI Rates

8 Mar, 2018 | 21:37h | UTC

Big Swings in Daily Temperatures Linked to Spikes in MI Rates – TCTMD (free)

Position Paper: Frailty and the management of patients with acute cardiovascular disease

8 Mar, 2018 | 21:36h | UTC

Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association – European Heart Journal: Acute Cardiovascular Care (free)

Position Paper: Antithrombotic therapy and body mass

8 Mar, 2018 | 21:35h | UTC

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis – European Heart Journal (free)

Research: Healthy diet may not offset high salt intake

8 Mar, 2018 | 21:33h | UTC

Relation of Dietary Sodium (Salt) to Blood Pressure and Its Possible Modulation by Other Dietary Factors: The INTERMAP Study – Hypertension (link to abstract – $ for full-text)

Commentaries: Healthy diet may not offset high salt intake – Imperial College London (free) AND Dietary sodium’s impact may not be offset by other aspects of a diet – AHA / ASA Newsroom (free)

Position Statement: Role of cardiopulmonary exercise testing in clinical stratification in heart failure

8 Mar, 2018 | 20:29h | UTC

Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology (free)

Reviews: Post-Contrast Acute Kidney Injury

8 Mar, 2018 | 20:18h | UTC

Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors – European Radiology (free)

Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients – European Radiology (free)

Source: Critical Care Reviews Newsletter

Review: Pneumonia as a cardiovascular disease

8 Mar, 2018 | 20:17h | UTC

Pneumonia as a cardiovascular disease – Respirology (free)

Source: Critical Care Reviews Newsletter

Research: Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI)

2 Mar, 2018 | 02:06h | UTC

Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial – European Heart Journal (free)

Commentaries: 3% rise in deaths for every 10 min delay in restoring blood flow after heart attack – OnMedica (free) AND Treatment Delay and Mortality in STEMI With Shock – American College of Cardiology, Latest in Cardiology (free)

Guidelines for the Use of Antiplatelet Therapy

2 Mar, 2018 | 01:57h | UTC

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy (free)

Research: Efficacy of self-monitored blood pressure for titration of antihypertensive medication

2 Mar, 2018 | 01:53h | UTC

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial – The Lancet (free)

Commentaries: Hypertension: time for doctors to switch the driver’s seat? (free) AND Should home-based blood pressure monitoring be commonplace in NHS? – University of Oxford News & Events (free)

“Self-monitoring, with or without telemonitoring, when used by general practitioners to titrate antihypertensive medication in individuals with poorly controlled blood pressure, leads to significantly lower blood pressure than titration guided by clinic readings”.

Guideline: pharmacological management of patients with type 2 diabetes and cardiovascular diseases

2 Mar, 2018 | 01:55h | UTC

2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases – Journal of the Chinese Medical Association (free)

Meta-Analysis: Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease

2 Mar, 2018 | 01:49h | UTC

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data – The Lancet (free)

This meta-analysis of randomized trials showed CABG had a mortality benefit over PCI in patients with multivessel disease, particularly those with diabetes and higher coronary complexity. There was no mortality benefit in patients with left main disease.

Meta-analysis: Long-Term Outcomes of On- Versus Off-Pump Coronary Artery Bypass Grafting

2 Mar, 2018 | 01:50h | UTC

Meta-analysis: Long-Term Outcomes of On- Versus Off-Pump Coronary Artery Bypass Grafting – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentary: Long-Term Outcomes of On- vs. Off-Pump CABG – American College of Cardiology, Latest in Cardiology (free)

“Off pump CABG. probably best used in a limited set of patients…” (via @keaglemd see Tweet)

Review: Cancer Diagnosis in Patients with Heart Failure

2 Mar, 2018 | 01:24h | UTC

Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge – European Journal of Heart Failure (free)

Research: Measures of General and Central Adiposity and the Risk of Myocardial Infarction

2 Mar, 2018 | 01:19h | UTC

Sex Differences in the Association Between Measures of General and Central Adiposity and the Risk of Myocardial Infarction: Results From the UK Biobank – Journal of the American Heart Association (free for a limited period)

Commentaries: Wait and hip measurement better indicator of heart attack risk than obesity – OnMedica (free) AND Larger waist, hips may raise women’s heart attack risk – MedicalNewsToday (free)

Impact of Bystander Automated External Defibrillator Use on Outcomes

2 Mar, 2018 | 01:11h | UTC

Impact of Bystander Automated External Defibrillator Use on Survival and Functional Outcomes in Shockable Observed Public Cardiac Arrests – Circulation (free PDF for a limited period)

Commentary: Bystander defibrillator use tied to better cardiac arrest outcomes – Reuters (free)

FDA Safety Alert: Clarithromycin Associated with Increased Risk of Heart Problems or Death in Patients With Heart Disease

2 Mar, 2018 | 00:59h | UTC

FDA Safety Alert: Clarithromycin (Biaxin): Drug Safety Communication – Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease (free)

Commentaries: FDA: Antibiotic Linked to Increased Risk of Death in Heart Disease Patients – MPR (free) AND FDA: Clarithromycin Risks Persist in Patients With CAD – TCTMD (free) FDA Alert: Clarithromycin Risky in Patients With Heart Disease – Medscape (free registration required)

Research: Spironolactone Vs Clonidine for Resistant Hypertension

2 Mar, 2018 | 00:54h | UTC

Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment) – Hypertension

Commentary: Spironolactone bests clonidine as fourth drug for resistant hypertension – Univadis (free registration required)

An Evidence-Based Approach to Pressors in Shock

1 Mar, 2018 | 22:12h | UTC

An Evidence-Based Approach to Pressors in Shock: Part I – emDocs (free)

An Evidence-Based Approach to Pressors in Shock: Part II – emDocs (free)